Warning: fopen(/home/virtual/colon/journal/upload/ip_log/ip_log_2024-11.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96
1Department of Surgery, Busan Hangun Hospital, Busan, Korea
2Department of Surgery, Hangun Hospital Bumcheon Campus, Busan, Korea
© 2024 The Korean Society of Coloproctology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: ISJ, SHH; Data curation: ISJ, SHH; Formal analysis: ISJ; Investigation: all authors; Methodology: ISJ, SHH; Project administration: all authors; Resources: ISJ, HMY, HJ; Software: ISJ; Supervision: SHH; Validation: ISJ, SHH, HJ; Visualization: ISJ, SHH, HJ; Writing–original draft: all authors; Writing–review & editing: all authors. All authors read and approved the final manuscript.
Characteristic | Value |
---|---|
Age (yr) | 47.5 (28–71) |
Sex | |
Female | 2 (9.1) |
Male | 20 (90.9) |
Underlying disease | |
Diabetes mellitus | 4 (18.2) |
Ulcerative colitis | 1 (4.5) |
Previous operation | 4 (1–10) |
Duration of fistula (mo) | 13 (6–360) |
Parks classification [9] at the first visit to our hospital | |
Type 1 | 0 (0) |
Type 2 | 2 (9.1) |
Type 3 | 8 (36.4) |
Type 4 | 12 (54.5) |
Inflammation | |
Sinus | 5 (22.7) |
Diffuse infiltrative | 10 (45.5) |
Mixed | 7 (31.8) |
Amount of stromal vascular fraction (mL) | 6 (2–7) |
Amount of scaffold (mL) | 23.5 (10–32) |
Improvement extent at 3 mo after surgery | |
Complete remission | 19 (86.4) |
Partial remission | 1 (4.5) |
No improvement | 2 (9.1) |
Follow-up (mo) | 15.5 (3–36) |
Patient no. | Sex | Age (yr) | Underlying disease | No. of surgery | Duration of fistula (mo) | Parks classification [9] | Inflammation feature | SVF (mL) | Scaffold (mL) | Outcome at 3 mo after surgery |
---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 64 | 7 | 360 | Type 4 | S+DI | 4.0 | 21.0 | No improvement | |
2 | Male | 65 | Diabetes mellitus | 6 | 9 | Type 4 | DI | 2.0 | 20.0 | Complete remission |
3 | Female | 51 | 4 | 14 | Type 4 | S | 6.5 | 25.0 | Complete remission | |
4 | Male | 46 | 4 | 12 | Type 4 | DI | 5.0 | 10.0 | Complete remission | |
5 | Male | 58 | 3 | 360 | Type 4 | DI | 7.0 | 18.0 | Complete remission | |
6 | Male | 49 | Diabetes mellitus | 5 | 8 | Type 4 | DI | 5.0 | 16.0 | Complete remission |
7 | Male | 54 | 2 | 6 | Type 4 | DI | 6.0 | 23.0 | Complete remission | |
8 | Male | 62 | 5 | 15 | Type 4 | S | 6.0 | 28.0 | Complete remission | |
9 | Male | 50 | 2 | 6 | Type 3 | S+DI | 6.0 | 15.0 | Complete remission | |
10 | Male | 49 | 4 | 21 | Type 3 | S | 5.8 | 25.0 | Complete remission | |
11 | Male | 34 | 4 | 7 | Type 4 | S | 5.0 | 24.0 | Complete remission | |
12 | Male | 71 | Diabetes mellitus | 2 | 6 | Type 4 | DI | 7.0 | 25.0 | Complete remission |
13 | Female | 37 | 6 | 18 | Type 3 | S+DI | 7.0 | 20.0 | No improvement | |
14 | Male | 42 | Ulcerative colitis | 3 | 10 | Type 3 | DI | 6.0 | 29.0 | Complete remission |
15 | Male | 55 | 10 | 360 | Type 4 | S+DI | 5.0 | 26.0 | Complete remission | |
16 | Male | 40 | 10 | 21 | Type 3 | S+DI | 6.1 | 23.0 | Complete remission | |
17 | Male | 41 | 3 | 7 | Type 3 | DI | 6.2 | 28.0 | Complete remission | |
18 | Male | 38 | Diabetes mellitus | 5 | 19 | Type 4 | DI | 6.8 | 25.0 | Complete remission |
19 | Male | 44 | 3 | 15 | Type 3 | S+DI | 6.9 | 32.0 | Complete remission | |
20 | Male | 42 | 2 | 8 | Type 2 | S+DI | 7.0 | 13.0 | Complete remission | |
21 | Male | 41 | 8 | 68 | Type 3 | S | 5.1 | 29.0 | Partial improvement | |
22 | Male | 28 | 1 | 6 | Type 2 | DI | 5.2 | 20.0 | Complete remission |
Characteristic | Value |
---|---|
Age (yr) | 47.5 (28–71) |
Sex | |
Female | 2 (9.1) |
Male | 20 (90.9) |
Underlying disease | |
Diabetes mellitus | 4 (18.2) |
Ulcerative colitis | 1 (4.5) |
Previous operation | 4 (1–10) |
Duration of fistula (mo) | 13 (6–360) |
Parks classification [9] at the first visit to our hospital | |
Type 1 | 0 (0) |
Type 2 | 2 (9.1) |
Type 3 | 8 (36.4) |
Type 4 | 12 (54.5) |
Inflammation | |
Sinus | 5 (22.7) |
Diffuse infiltrative | 10 (45.5) |
Mixed | 7 (31.8) |
Amount of stromal vascular fraction (mL) | 6 (2–7) |
Amount of scaffold (mL) | 23.5 (10–32) |
Improvement extent at 3 mo after surgery | |
Complete remission | 19 (86.4) |
Partial remission | 1 (4.5) |
No improvement | 2 (9.1) |
Follow-up (mo) | 15.5 (3–36) |
Patient no. | Sex | Age (yr) | Underlying disease | No. of surgery | Duration of fistula (mo) | Parks classification [9] | Inflammation feature | SVF (mL) | Scaffold (mL) | Outcome at 3 mo after surgery |
---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 64 | 7 | 360 | Type 4 | S+DI | 4.0 | 21.0 | No improvement | |
2 | Male | 65 | Diabetes mellitus | 6 | 9 | Type 4 | DI | 2.0 | 20.0 | Complete remission |
3 | Female | 51 | 4 | 14 | Type 4 | S | 6.5 | 25.0 | Complete remission | |
4 | Male | 46 | 4 | 12 | Type 4 | DI | 5.0 | 10.0 | Complete remission | |
5 | Male | 58 | 3 | 360 | Type 4 | DI | 7.0 | 18.0 | Complete remission | |
6 | Male | 49 | Diabetes mellitus | 5 | 8 | Type 4 | DI | 5.0 | 16.0 | Complete remission |
7 | Male | 54 | 2 | 6 | Type 4 | DI | 6.0 | 23.0 | Complete remission | |
8 | Male | 62 | 5 | 15 | Type 4 | S | 6.0 | 28.0 | Complete remission | |
9 | Male | 50 | 2 | 6 | Type 3 | S+DI | 6.0 | 15.0 | Complete remission | |
10 | Male | 49 | 4 | 21 | Type 3 | S | 5.8 | 25.0 | Complete remission | |
11 | Male | 34 | 4 | 7 | Type 4 | S | 5.0 | 24.0 | Complete remission | |
12 | Male | 71 | Diabetes mellitus | 2 | 6 | Type 4 | DI | 7.0 | 25.0 | Complete remission |
13 | Female | 37 | 6 | 18 | Type 3 | S+DI | 7.0 | 20.0 | No improvement | |
14 | Male | 42 | Ulcerative colitis | 3 | 10 | Type 3 | DI | 6.0 | 29.0 | Complete remission |
15 | Male | 55 | 10 | 360 | Type 4 | S+DI | 5.0 | 26.0 | Complete remission | |
16 | Male | 40 | 10 | 21 | Type 3 | S+DI | 6.1 | 23.0 | Complete remission | |
17 | Male | 41 | 3 | 7 | Type 3 | DI | 6.2 | 28.0 | Complete remission | |
18 | Male | 38 | Diabetes mellitus | 5 | 19 | Type 4 | DI | 6.8 | 25.0 | Complete remission |
19 | Male | 44 | 3 | 15 | Type 3 | S+DI | 6.9 | 32.0 | Complete remission | |
20 | Male | 42 | 2 | 8 | Type 2 | S+DI | 7.0 | 13.0 | Complete remission | |
21 | Male | 41 | 8 | 68 | Type 3 | S | 5.1 | 29.0 | Partial improvement | |
22 | Male | 28 | 1 | 6 | Type 2 | DI | 5.2 | 20.0 | Complete remission |
Values are presented as median (range) or number (%).
SVF, stromal vascular fraction; S, sinus; DI, diffuse infiltrative.